ММВБ 3 772 -0,9%  Nasdaq 14 673 -0,7%  Биткойн 41 859 0,3%  USD/RUB 73,1370 0,0% 
РТС 1 626 -0,8%  S&P500 4 395 -0,5%  Нефть 76,3 0,5%  EUR/RUB 86,8105 0,0% 
Dow 34 935 -0,4%  FTSE100 7 032 -0,7%  Золото 1 787 -1,5%  EUR/USD 1,1869 0,0% 

Ultimovacs AS Registered Shs - Профиль

Ultimovacs AS is a pharmaceutical company, which engages in the development of novel immunotherapies against cancer. Its product, UV1, is a therapeutic cancer vaccine that activates the immune system to recognize telomerase. The company was founded on January 26, 2011 and is headquartered in Oslo, Norway.

Акционеры

Название Доля (%)
Freefloat39,79
Bjørn Rune Gjelsten19,30
Hagen Stein Erik Family7,93
Inven2 AS5,84
Wilhelmsen Family5,44
FIL Investment Advisors (UK) Ltd.5,01
Radiumhospitalets Forskningsstiftelse4,69
Langøya Invest AS4,22
Christian Gruner Sundt2,76
Else Helene Sundt2,76
Nordea Investment Management AB (Norway)2,59
Fidelity Funds SICAV - European Smaller Companies Fund2,27
Månebakken AS1,84
Gustav Gaudernack1,74
Nordea Avkastning1,63

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент